EW
37
-2
M
20
-4
CAG
30
4
XEL
67
2
ED
48
3
UHS
54
3
EQIX
60
-2
PVH
52
-3
NTAP
64
2
NWSA
62
2
USB
50
2
NAVI
41
-3
PRU
57
-3
K
53
2
HPE
55
11
PNW
66
3
AVGO
20
-5
MUR
43
3
SYK
64
-4
IBM
54
4
EW
37
-2
M
20
-4
CAG
30
4
XEL
67
2
ED
48
3
UHS
54
3
EQIX
60
-2
PVH
52
-3
NTAP
64
2
NWSA
62
2
USB
50
2
NAVI
41
-3
PRU
57
-3
K
53
2
HPE
55
11
PNW
66
3
AVGO
20
-5
MUR
43
3
SYK
64
-4
IBM
54
4
Financhill
Back

AIM ImmunoTech Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26

AIM
AIM ImmunoTech

Last Price:
0.21
Seasonality Move:
1.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

AIM ImmunoTech Price Quote

$0.21
+0.01 (+5%)
(Updated: November 21, 2024 at 2:05 PM ET)

AIM ImmunoTech Key Stats

Sell
26
AIM ImmunoTech (AIM) is a Sell
Day range:
$0.18 - $0.20
52-week range:
$0.21 - $0.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
57.26
P/B ratio:
2.39%
Volume:
1M
Avg. volume:
507.1K
1-year change:
-51.69%
Market cap:
$14.6M
Revenue:
$202K
EPS:
$-0.57

How Much Does AIM ImmunoTech Make?

Is AIM ImmunoTech Growing As A Company?

  • What Is AIM ImmunoTech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.19%
  • What Is AIM ImmunoTech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

AIM ImmunoTech Stock Price Performance

  • Did AIM ImmunoTech Stock Go Up Last Month?
    AIM ImmunoTech share price went down by -20.13% last month
  • Did AIM's Share Price Rise Over The Last Year?
    AIM share price fell by -51.69% over the past 1 year

What Is AIM ImmunoTech 52-Week High & Low?

AIM ImmunoTech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AIM ImmunoTech?

  • How Much Debt Does AIM ImmunoTech Have?
    Total long term debt quarterly is $2.6M
  • How Much Cash Does AIM ImmunoTech Have?
    Cash and short term investments quarterly total is $10.1M
  • What Is AIM ImmunoTech’s Book Value Per Share?
    Book value per share is 0.11

Is AIM ImmunoTech Cash Flow Positive?

  • What Is AIM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$23.3M
  • What Is AIM ImmunoTech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.7M
  • What Is AIM ImmunoTech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $118K

AIM ImmunoTech Return On Invested Capital

  • Is Management Doing A Good Job?
    AIM return on invested capital is -177.26%
  • What Is AIM ImmunoTech Return On Assets?
    ROA measures how assets are converting to revenues and is -124.35%
  • What Is AIM Return On Equity?
    ROE is a measure of profitability and is -189.75%

AIM ImmunoTech Earnings Date & Stock Price

AIM ImmunoTech Competitors

  • Who Are AIM ImmunoTech's Competitors?
    Below is a list of companies who compete with AIM ImmunoTech or are related in some way:
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Protalix BioTherapeutics Inc (PLX)
    • Xtant Medical Holdings Inc (XTNT)

AIM ImmunoTech Dividend Yield

AIM ImmunoTech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20.5%
Revenue: 19.05% 199.91%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.17
Upside from Last Price: 1483.34%

Major Shareholders

  • How many AIM shares are owned by institutional investors?
    10.6M AIM shares are owned by institutional investors
  • How many AIM shares are owned by insiders?
    5M AIM shares are owned by insiders